AACC welcomes you. We prefer to discuss any question about your document by phone rather than email, Please call us at (202) 347-5800.
When a U.S. drug or medical device is made for export and isn’t marketed in the United States, the FDA issues a Certificate of Exportability instead of a CFG or COPP. For Algeria, that FDA-signed certificate receives a federal apostille from the U.S. Department of State, with no notary or state step. Since July 9, 2026, the Algerian Embassy is no longer involved.
Export-only products, federal certificate. The FDA issues the Certificate of Exportability under sections 801(e) and 802 of the FD&C Act. The Office of Authentications apostilles it as issued. Note that it is not proof of U.S. free sale, so the ANPP or your importer may request other evidence.
Not every product a U.S. company ships to Algeria is sold at home. A medicine may be made in a strength or pack size approved only abroad, a medical device may be built to a specification for the Algerian market, or labeling may be prepared in Arabic and French with claims that differ from U.S. labeling. For these products, the FDA cannot issue a Certificate to Foreign Government or a COPP, because those certificates attest to U.S. marketing. The FDA instead issues a Certificate of Exportability.
Under sections 801(e) and 802 of the Federal Food, Drug, and Cosmetic Act, products that are not approved or not marketed in the U.S. can still be lawfully exported if they meet certain conditions, including meeting the importing country’s specifications and not conflicting with its laws. The Certificate of Exportability confirms that the exporter has represented that the product meets those export conditions. It does not say the product is sold in the United States, and Algerian reviewers know the difference.
Because a Certificate of Exportability is not proof of free sale, the ANPP (for medicines and medical devices) or the importer may ask for additional evidence that the product is authorized somewhere: for example, a free sale or marketing authorization from another country where it is sold, or a fuller technical justification. Discuss the dossier with your Algerian regulatory agent before applying to the FDA. The answer can decide which certificate you request and which other country’s documents you also need.
Exportability certificates for medical devices come from the Center for Devices and Radiological Health (CDRH), and those for human drugs from the Center for Drug Evaluation and Research (CDER). The application describes the product and the destination, so name Algeria and match the product description to the Algerian file.
The certificate carries an FDA official’s signature, so its authentication belongs to the federal government. It is presented as issued, without notarization or any state involvement, to the Office of Authentications at the U.S. Department of State, which attaches the apostille. Algeria began accepting apostilles on July 9, 2026, so that single federal certification now completes the document for Algerian use, and the former Algerian Embassy legalization no longer applies.
Keep the exported product’s labeling, specifications and certificate wording consistent, and keep records showing that the product meets Algerian requirements. These are part of the exporter’s obligations under U.S. export rules, and they also answer the questions an Algerian reviewer is most likely to ask.
A model or configuration not sold in the U.S.
CDRHA strength, form or pack approved only abroad.
CDERArabic and French labeling with different claims.
LabelingMade in the U.S. for a foreign brand owner.
Export onlyPitfalls with this certificate: presenting it as proof of U.S. free sale, a product description that differs from the dossier, applying for a CFG when the product isn’t marketed in the U.S., adding a notarization, or routing it through a state office or the Algerian Embassy.
| Document | FDA-issued certificate |
| Notarization | None (federal signature) |
| Authentication | Federal apostille |
| Apostille | Set by the federal Office of Authentications |
| Embassy step | Ended July 2026 |
| Return | Tracked courier |
Combine exportability certificates with CFGs or COPPs for other products in the same order.
Arab Chamber of Commerce
1615 Bay Head Rd., Annapolis, MD 21409
(410) 349-1212
1330 New Hampshire Ave. NW, B1, Washington, DC
(202) 347-5800
Monday to Friday, 8:00 am to 6:00 pm ET
When the drug or device is not marketed in the U.S. A CFG or COPP attests to U.S. marketing, so it cannot be issued for an export-only product.
No. It confirms the product meets the export conditions of FD&C Act sections 801(e) and 802. The ANPP may ask for other proof of authorization.
The Office of Authentications at the U.S. Department of State, with an apostille on the certificate as issued.
No. Algeria has accepted apostilles since July 9, 2026, so the embassy legalization step has ended.
CDRH for medical devices and CDER for human drugs.
Send us your FDA certificates. We’ll handle the federal apostille.
If you are using FedEx or UPS, please include a self-addressed air waybill for the return of your document.
Alternatively, you may use a USPS Priority Mail envelope with prepaid postage and a tracking number.
If you do not have a FedEx or UPS account, you can purchase an air waybill through this site in the next step.